Chas P. Smith & Associates (CPS)’s Allergan plc AGN Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-940	Closed	-$229K	–	101
2017 Q2	$229K	Sell	940 -14,965	-94%	-$3.52M	0.03%	87
2017 Q1	$3.8M	Sell	15,905 -1,841	-10%	-$429K	0.56%	39
2016 Q4	$3.73M	Sell	17,746 -34,085	-66%	-$7.06M	0.59%	39
2016 Q3	$13.9M	Buy	51,831 +24,260	+88%	+$5.93M	1.18%	32
2016 Q2	$6.37M	Sell	27,571 -2,752	-9%	-$635K	1.07%	35
2016 Q1	$8.13M	Sell	30,323 -1,631	-5%	-$467K	1.39%	28
2015 Q4	$9.99M	Buy	31,954 +3,273	+11%	+$974K	1.76%	27
2015 Q3	$7.8M	Buy	28,681 +2,162	+8%	+$664K	1.5%	31
2015 Q2	$8.05M	Buy	26,519 +9,404	+55%	+$2.8M	1.41%	30
2015 Q1	$5.09M	Buy	+17,115	New	+$4.88M	0.91%	36

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Chas P. Smith & Associates (CPS)'s AGN Position: Q3 2017 in Review

Chas P. Smith & Associates (CPS) sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 940 shares — an estimated $229K sold.

Chas P. Smith & Associates (CPS) first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $13.9M in Q3 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Chas P. Smith & Associates (CPS) reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Chas P. Smith & Associates (CPS) sold 940 Allergan plc shares in Q3 2017, an estimated $229K.
Chas P. Smith & Associates (CPS) first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
Chas P. Smith & Associates (CPS)'s Allergan plc position peaked at $13.9M in Q3 2016.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q3 2017, filed 31 Oct 2017.